Search - tctmd.com

Displaying 21 - 40 of 46

Sort: Relevancy | Date

Presentation THT 2025

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

Presenter: Mark Petrie

February 11, 2025

Presentation TCT 2024

CON: Too Early or Too Risky

Presenter: Kevin Bainey

October 29, 2024

Presentation TCT 2024

PRO: Time is Now: Targeting Acute Inflammation and Residual Inflammatory Risk

Presenter: Vijay Kunadian

October 29, 2024

Presentation TCT 2024

Role of Inflammation in Coronary Heart Disease: Why Does it Matter

Presenter: Deepak Bhatt

October 29, 2024

Presentation TCT 2024

TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model

Presenter: Seok Oh

October 29, 2024

Presentation TCT 2024

Inflammation- Current and Emerging Therapeutic Landscape

Presenter: Deepak Bhatt

October 29, 2024

Presentation TCT 2024

What Comes Next? Role of Inflammation on AMI

Presenter: Kevin Bainey

October 28, 2024

Presentation TCT 2024

Inflammation: The Next Frontier

Presenter: Vijay Kunadian

October 28, 2024

Presentation Complex Coronary Cases 2023

Eliminating Coronary Artery Disease: Targeting Hypercholesterolemia and Inflammation

Presenter: Marc S. Sabatine

June 15, 2023

Presentation Controversies and Advances 2021

Pathways for Inflammation in Athero-thrombosis Focus on Inflammasome

Presenter: P. K. Shah

December 03, 2021

Presentation TCT 2019

Novel Approaches in Diabetic Patients After PCI: Role of SGLT2 Inhibitors and Potent Antiplatelet Therapy (THEMIS)

Presenter: Marc Bonaca

September 26, 2019

Presentation TCT 2019

Tackling Inflammation: Novel Targets

Presenter: Wolfgang Koenig

September 26, 2019

Presentation TCT 2019

LP(a): Not So Little Anymore

Presenter: Roberta Rossini

September 26, 2019

Presentation TCT 2019

Don’t Forget About Your HDL: The AEGIS Program

Presenter: C. Michael Gibson

September 26, 2019

Presentation TCT 2019

Role of PCSK9 Inhibitors Post-PCI and ACS

Presenter: Marc Bonaca

September 26, 2019

Presentation TCT 2019

Loading Dose Statin Prior PCI: Is There a Role For It?

Presenter: Renato Lopes

September 26, 2019

Presentation TCT 2018

TCT-56: High-Resolution Intravascular OCT-NIRF Molecular Imaging for In Vivo Assessment of Inflammation in Atherosclerosis and Vascular Injury

Presenter: John A. Ambrose, Farouc A Jaffer, Zhonglie Piao

September 21, 2018

Presentation Controversies and Advances 2017

Targeting Inflammation in Atherosclerosis: Has CANTOS Nailed It?

Presenter: Sanjay Kaul

November 16, 2017

Presentation TCT 2016

YELLOW II: Relationship of Serial Change in Plaque Morphology of Obstructive Non-Culprit Lesions to HDL Efflux, Inflammation and Transcriptome Perturbations in Response to High-Dose Statin Therapy

Presenter: Spencer B. King III, Jagat Narula, Annapoorna Kini

October 31, 2016

Presentation

Relationship Between Inflammation and Benefits of Early High-Dose Rosuvastatin on CIN in ACS Patients

Presenter: Anna Toso

December 15, 2014

Advertisement

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

CON: Too Early or Too Risky

PRO: Time is Now: Targeting Acute Inflammation and Residual Inflammatory Risk

Role of Inflammation in Coronary Heart Disease: Why Does it Matter

TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model

Inflammation- Current and Emerging Therapeutic Landscape

What Comes Next? Role of Inflammation on AMI

Inflammation: The Next Frontier

Eliminating Coronary Artery Disease: Targeting Hypercholesterolemia and Inflammation

Pathways for Inflammation in Athero-thrombosis Focus on Inflammasome

Novel Approaches in Diabetic Patients After PCI: Role of SGLT2 Inhibitors and Potent Antiplatelet Therapy (THEMIS)

Tackling Inflammation: Novel Targets

LP(a): Not So Little Anymore

Don’t Forget About Your HDL: The AEGIS Program

Role of PCSK9 Inhibitors Post-PCI and ACS

Loading Dose Statin Prior PCI: Is There a Role For It?

TCT-56: High-Resolution Intravascular OCT-NIRF Molecular Imaging for In Vivo Assessment of Inflammation in Atherosclerosis and Vascular Injury

Targeting Inflammation in Atherosclerosis: Has CANTOS Nailed It?

YELLOW II: Relationship of Serial Change in Plaque Morphology of Obstructive Non-Culprit Lesions to HDL Efflux, Inflammation and Transcriptome Perturbations in Response to High-Dose Statin Therapy

Relationship Between Inflammation and Benefits of Early High-Dose Rosuvastatin on CIN in ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content